Table 1.
Study | Subjects (n) | Diagnosis | Study Design | Comparison Treatment | Outcome Measure | Risk Reduction | Comments |
---|---|---|---|---|---|---|---|
Aripiprazole | |||||||
Weisler et al. 2011 [89] | 737 | MDD | Pooled RCTs | Placebo | Suicidal ideation | ––– | Ariprazole effective |
Ringbäck-Weitoft et al. 2014 [44] | 720 | Sz | National database | APs, SGAs | Suicide | OR: 0.21 [0.05–0.94] | Ariprazole effective |
Asenapine | |||||||
Azorin et al. 2013 [87] | 295 | BD-I | Pooled RCTs | Olanzapine | Depression | ––– | Asenapine effective vs. depression & suicidal ideation |
Clozapine | |||||||
Meltzer et al. 2003 [38] | 980 | Sz | RCT | Olanzapine | Suicidal behavior | HR: 0.76 [0.58–0.97] | Clozapine superior |
Modestin et al. 2005 [43] | 94 | Sz | Chart review | ±ADs | Suicidal behavior | ––– | Clozapine effective ± antidepressants |
Haukka et al. 2008 [4] | 504 | Sz | National database | No treatment | Suicide | HR: 0.74 [0.35–1.57] | Clozapine reduced mortality |
Tiihonen et al. 2009 [5] | 32,000 | Sz | National database | Perphenazine | Suicide | HR: 0.34 [0·20–0·57] | Clozapine reduced mortality |
Ringbäck-Weitoft et al. 2014 [44] | 2138 | Sz | National database | APs, SGAs | Suicidal behavior | OR: 0.45 [0.20-0.98] | Clozapine more effective than haloperidol |
Thomas et al. 2015 [16] | ––– | Sz | Open trial | Olanzapine | Suicide attempt | ––– | Clozapine more effective than olanzapine vs. suicide attempts |
Olanzapine | |||||||
Tollefson et al. 1997 [49] | 1996 | Sz | RCT | Haloperidol | Negative symptoms | ––– | Olanzapine more effective vs. suicidal ideation & negative symptoms |
Tran et al. 1997 [48] | 339 | Sz | RCT | Risperidone | Negative symptoms | ––– | Olanzapine more effective vs. suicidal ideation & negative symptoms |
Barak et al. 2004 [50] | 756 | Sz | Case-control chart review | Risperidone or Neuroleptics | Suicide attempt | OR: 0.57 [0.30–0.83] | Olanzapine & risperidone more effective than neuroleptics |
Haukka et al. 2008 [4] | 394 | Sz | National database | No treatment | Suicide attempt | HR: 1.37 [0.87–2.14] | Olanzapine effective |
Tiihonen et al. 2009 [5] | 25,130 | Sz | National database | Perphenazine | Suicide | HR: 0.94 [0·61–1·45] | Olanzapine more effective |
Ringbäck-Weitoft et al. 2014 [44] | 3747 | Sz | National database | APs, SGAs | Suicide attempt | OR: 0.44 [0.28-0.70] | Olanzapine more effective |
Quetiapine | |||||||
Calabrese et al. 2005 [62] | 511 | BD-I+II | RCT | Placebo | Suicidal thoughts | ––– | Quetiapine more effective |
Cutler et al. 2009 [66] | 612 | MDD | RCT | Placebo | Suicidal thoughts | ––– | Quetiapine (150–300 mg/day) effective |
Suppes et al. 2009 [65] | 1953 | BD-I | RCT | Placebo | Depression | ––– | Quetiapine + lithium or + divalproex reduced new depression 67% |
Tiihonen et al. 2009 [5] | 5360 | Sz | National database | Perphenazine | Suicide | OR: 1.58 [0.89–2.79] | Quetiapine not effective |
El-Khalili et al. 2010 [70] | 446 | BD-I+II | RCT | Placebo | Suicidal thoughts | ––– | Quetiapine effective for suicidal thoughts, tension, insomnia |
McElroy et al. 2010 [64] | 740 | BD-I+II | RCT | Placebo | Depression | ––– | Quetiapine more effective vs. suicidal ideation & depression |
Young et al. 2010 [63] | 802 | BD-I+II | RCT | Placebo | Depression | ––– | Quetiapine effective vs. suicidal thoughts, tension, insomnia |
Weisler et al. 2014 [71] | 1766 | MDD | Pooled RCTs | Placebo | Suicidal behavior | ––– | No emergent suicidal behavior (drug or placebo) |
Ziprasidone | |||||||
Karayal et al. 2011 [79] | 5123 | BD-I+II | Pooled RCTs | Placebo | Suicidal behavior | ––– | No emergent suicidal behavior (drug or placebo) |
Abbreviations: AD, antidepressant; AP, antipsychotic; BD, bipolar disorder (type I or II); HR, Hazard Ratio; MDD, major depressive disorder; OR, Odds Ratio; SGA, second-generation antipsychotic; Sz, schizophrenia; RCT: randomized controlled trial; –––, no information. The 24 comparisons summarized here arise from 19 reports [4,5,38,43,44,46,48,49,50,62,63,64,65,66,70,71,79,87,89], and include over 86,896 subjects.